TriSalus Life Sciences, Inc.

MedTech Acquisition Corp, trading under the ticker MTAC, was a healthcare-focused special purpose acquisition company that completed its IPO in 2021 with sponsorship from MedTech Acquisition Partners. The August 2021 8-K filing, bearing accession number 0001104659-21-104628, pertains to the company's de-SPAC process targeting TriSalus Life Sciences, Inc., an interventional oncology company developing drug-delivery systems for liver and pancreatic cancers. The combination represented MTAC's entry into the medical device and oncology therapeutics sector. The transaction ultimately brought TriSalus Life Sciences to public markets through the SPAC vehicle. Sign up at SpacDesk for full filing history, timeline data, and deal analytics on MTAC and hundreds of other SPAC transactions.